Trending stocks today
Kenvue (KVUE-N)
NYSE:KVUE
20.61
0.20
(0.96%) 1d
Financials
Technical Analysis
Buy, Sell or Hold?
N/A
Owned
A JNJ spin-off, done with a lot of debt which gives him pause. Their PE is high. Is really concerned is that JNJ also spun off the liability to the talcum powder lawsuits which KVUE now carries.
He owns JNJ. Lots of regard for KVUE, but hasn't initiated a position. Needs a period of seasoning to transition from IPO to reality. He's watching and waiting. Meaningful discount to CHD, but of similar quality.
Consumer products spinoff from Johnson & Johnson.
Would not buy at current share price (19x earnings).
Growth is slow (3-4%).
Sees better opportunities elsewhere.
Assumed product liability on products - very expensive.
- «
- ‹
- 1
- ›
- »
Kenvue(KVUE-N) Rating
Ranking : 3 out of 5
Bullish - Buy Signals / Votes : 0
Neutral - Hold Signals / Votes : 0
Bearish - Sell Signals / Votes : 2
Total Signals / Votes : 2
Kenvue(KVUE-N) Frequently Asked Questions
What is Kenvue stock symbol?
Kenvue is a American stock, trading under the symbol KVUE-N on the New York Stock Exchange (KVUE). It is usually referred to as NYSE:KVUE or KVUE-N
Is Kenvue a buy or a sell?
In the last year, 2 stock analysts published opinions about KVUE-N. 0 analysts recommended to BUY the stock. 2 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Kenvue.
Is Kenvue a good investment or a top pick?
Kenvue was recommended as a Top Pick by on . Read the latest stock experts ratings for Kenvue.
Why is Kenvue stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
Is Kenvue worth watching?
In the last year, there was no coverage of Kenvue published on Stockchase.
What is Kenvue stock price?
On 2023-12-08, Kenvue (KVUE-N) stock closed at a price of $20.61.
Consumer health spinoff from J&J. First rate consumer products business. Trading at discount to peers in sector. ~4% dividend attractive. Excellent array of brands in portfolio. Litigation always a concern, but overall not worried for the long term.